Literature DB >> 12492487

The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G.

Yasushi Haga1, Ken Yanagisawa, Hiromi Ohto-Ozaki, Shin-Ichi Tominaga, Toshio Masuzawa, Hiroyuki Iwahana.   

Abstract

The ST2 gene, which is specifically induced by growth stimulation in fibroblasts, encodes interleukin-1 receptor-related proteins and is widely expressed in hematopoietic, helper T, and various cancer cells. However, the physiological as well as pathological functions of the ST2 gene products are not yet fully understood. In this study, we analyzed the expression of the ST2 gene in human glioma cell lines and human brain tumor samples with real-time polymerase chain reaction method, the results of which revealed that the expression level of the ST2 gene in glioma cell lines and glioblastoma samples is significantly lower than that in a fibroblastic cell line, TM12, and benign brain tumors, suggesting the reverse relationship between malignancy and ST2 expression. As we could not detect the soluble ST2 protein in the culture fluid of the T98G glioblastic cell line by ELISA, we established stable transformants of T98G that continuously produce and secrete the ST2 protein, in order to study the effect of the ST2 protein on malignancy. Although we could not detect a remarkable difference in proliferation between transformants and control cells in conventional tissue culture dishes, the efficiency of colony formation in soft agar was significantly decreased in the case of cells that continuously produce the ST2 protein. Furthermore, inhibition of colony formation in soft agar was observed in wild-type T98G cells when purified soluble ST2 protein was added to the culture, in a dose-dependent manner. Taken together, the results suggest that the expression of ST2 suppressed the anchorage-independent growth and malignancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492487     DOI: 10.1046/j.1432-1033.2003.03377.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Research progress on interleukin-33 and its roles in the central nervous system.

Authors:  Ping Han; Wen-Li Mi; Yan-Qing Wang
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

2.  Decreased ST2 expression is associated with gastric cancer progression and pathogenesis.

Authors:  Feihu Bai; Fangyun Ba; Yanjie You; Yaning Feng; Wei Tao; Chuanxia Wu; Mengna Jiu; Yongzhan Nie
Journal:  Oncol Lett       Date:  2019-04-05       Impact factor: 2.967

Review 3.  Disease-associated functions of IL-33: the new kid in the IL-1 family.

Authors:  Foo Y Liew; Nick I Pitman; Iain B McInnes
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

4.  Changes of nuclear matrix proteins following the differentiation of human osteosarcoma MG-63 cells.

Authors:  Chun-Hong Zhao; Qi-Fu Li; Yan Zhao; Jing-Wen Niu; Zhi-Xing Li; Jin-An Chen
Journal:  Genomics Proteomics Bioinformatics       Date:  2006-02       Impact factor: 7.691

5.  STAT3 and ERK pathways are involved in cell growth stimulation of the ST2/IL1RL1 promoter.

Authors:  Kenji Tago; Satoshi Ohta; Megumi Funakoshi-Tago; Chihiro Aoki-Ohmura; Jitsuhiro Matsugi; Shin-Ichi Tominaga; Ken Yanagisawa
Journal:  FEBS Open Bio       Date:  2017-01-19       Impact factor: 2.693

6.  ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant.

Authors:  Kenji Tago; Satoshi Ohta; Masaki Kashiwada; Megumi Funakoshi-Tago; Jitsuhiro Matsugi; Shin-Ichi Tominaga; Ken Yanagisawa
Journal:  Heliyon       Date:  2017-10-31

7.  Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells.

Authors:  Shin-Ichi Tominaga; Satoshi Ohta; Kenji Tago
Journal:  Biochem Biophys Rep       Date:  2015-11-21

8.  Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma.

Authors:  Susanne Flor; Claudia R Oliva; Md Yousuf Ali; Kristen L Coleman; Jeremy D Greenlee; Karra A Jones; Varun Monga; Corinne E Griguer
Journal:  Antioxidants (Basel)       Date:  2021-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.